Home |  Site Map |  Inquire Now |  Shuangweibio
 
Clinical Efficacy of Phase Leukocyte Reduction Filters in High-risk Patients (2)
Home > News > Industry News > Clinical Efficacy of Phase Leukocyte Reduction Filters in High-risk Patients (2)

Clinical Efficacy of Phase Leukocyte Reduction Filters in High-risk Patients (2)


Leukocyte reduction filters and strategic filtration groups demonstrated significant differences. Demonstrated well preserved myocardium in double filter group. Brain natriuretic peptide levels in double filter group were significantly lower with respect to group and control. Matrixmetallopeptidase and dimer levels in double filter group were significantly lower.Two-phase leukofiltration is associated with some compound benefit over continuous deployment in high-risk patients. A larger more powerful study than this pilot one is warranted for further evaluation. Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model.

back

What's New
Multi Color Orthopaedic Fiberglass Casting Tapes
Our Business
Contact Us
Tel: 86-25-58847598
                 58745027
Fax: 86-25-58745107
Email:njswbio@gmail.com
Product Categories
armor-wrap chinese coal buyers coal buyer coal importer Leukocyte Reduction Filters Orthopedic Casting Tapes Resources steam coal buyer thermal coal buyers | Friendly Links
Certificates | Contact Us | Privacy Policy | Rice Mill Plant | Sitemap
Shuangwei Biotechnology Co., Ltd. All Rights Reserved